These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 3666972)
1. Cystic fibrosis. Part I. Infection; 1987; 15(4):269-312. PubMed ID: 3666972 [No Abstract] [Full Text] [Related]
2. Cystic fibrosis lung disease: interplay of a microbial microcosm and extremes of inflammation. Blau H Isr Med Assoc J; 2006 Jan; 8(1):58-9. PubMed ID: 16450756 [No Abstract] [Full Text] [Related]
3. First isolations of Segniliparus rugosus from patients with cystic fibrosis. Butler WR; Sheils CA; Brown-Elliott BA; Charles N; Colin AA; Gant MJ; Goodill J; Hindman D; Toney SR; Wallace RJ; Yakrus MA J Clin Microbiol; 2007 Oct; 45(10):3449-52. PubMed ID: 17670929 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients. Traczewski MM; Brown SD Antimicrob Agents Chemother; 2006 Feb; 50(2):819-21. PubMed ID: 16436756 [TBL] [Abstract][Full Text] [Related]
5. [Respiratory infection in cystic fibrosis: burden of illness in the progression of cystic fibrosis, previous deductions for the microbiological study of bronchial secretions and clinical criteria of infection]. Thumerelle C Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S37-48. PubMed ID: 12910133 [No Abstract] [Full Text] [Related]
6. [Isolation of Scedosporium prolificans in patients with cystic fibrosis]. García E; Rodríguez V; Gartner S; Gené J Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):488-9. PubMed ID: 9918999 [No Abstract] [Full Text] [Related]
11. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey. Ojeniyi B APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis. Van Devanter DR Respiration; 2007; 74(3):356; author reply 357. PubMed ID: 17204830 [No Abstract] [Full Text] [Related]
13. Aspergillus organisms in patients with cystic fibrosis. Taccetti G; Campana S; Marianelli L Pediatr Pulmonol; 1997 Apr; 23(4):317-8. PubMed ID: 9141120 [No Abstract] [Full Text] [Related]
14. Burkholderia cepacia in cystic fibrosis. Govan JR N Engl J Med; 1995 Mar; 332(12):819-20; author reply 820-1. PubMed ID: 7532285 [No Abstract] [Full Text] [Related]
15. Cost effectiveness analysis in cystic fibrosis. Doran C; Vos T J Cyst Fibros; 2005 Dec; 4(4):211-2. PubMed ID: 16230054 [No Abstract] [Full Text] [Related]
16. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis. Agarwal G; Kapil A; Kabra SK; Das BK Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494 [No Abstract] [Full Text] [Related]
17. [What is the burden of respiratory infection in the progression of cystic fibrosis]. Bellon G Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S49-55. PubMed ID: 12910134 [No Abstract] [Full Text] [Related]
18. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients]. Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760 [TBL] [Abstract][Full Text] [Related]
19. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?]. David V Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143 [No Abstract] [Full Text] [Related]